← Open Payments lookup

JESSICA ZARZYCKI: Open Payments

NPI 1245748375 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,227 in 56 payments from 13 companies in 2025. Trend: 2023 $501 · 2024 $900 · 2025 $1,227

Food & beverage: $1,148Education: $79
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$360
ABBVIE INC.15$252
Janssen Biotech, Inc.7$232
Intercept Pharmaceuticals, Inc.3$84
Takeda Pharmaceuticals U.S.A., Inc.4$78
Lilly USA, LLC3$65
PFIZER INC.1$24
Phathom Pharmaceuticals, Inc.1$24
Aimmune Therapeutics, Inc.1$23
Celltrion USA Inc.1$22

Products named: XIFAXAN, TREMFYA, RINVOQ, OCALIVA, LINZESS, MAVYRET, OMVOH, DUPIXENT.

Industry payments across PA — which companies pay providers there.